HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation.

Abstract
We present a case of adenovirus (ADV) infection in a patient who had undergone nonmyeloablative stem cell transplantation (NST). A 50-year-old man with chronic myelogenous leukemia in the second chronic phase underwent NST from an HLA 2-loci-mismatched sibling. ADV hemorrhagic cystitis developed and progressed to lethal pneumonia. ADV was isolated from urine, bronchoalveolar lavage fluid, and postmortem specimens of kidney and liver. Because there are few reports of lethal pneumonia associated with ADV in Japan, we present the case and discuss the cause of and therapy for the infection.
AuthorsK Ikegame, T Takimoto, R Takahashi, M Murakami, H Tamaki, T Fujioka, M Kawakami, N Hirabayashi, T Soma, H Sugiyama, H Ogawa
JournalInternational journal of hematology (Int J Hematol) Vol. 74 Issue 1 Pg. 95-100 (Jul 2001) ISSN: 0925-5710 [Print] Japan
PMID11530814 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Vidarabine
  • Busulfan
  • fludarabine
  • Tacrolimus
  • Methylprednisolone
Topics
  • Adenoviridae Infections (etiology)
  • Adenoviruses, Human (isolation & purification)
  • Antilymphocyte Serum
  • Bronchoalveolar Lavage Fluid (virology)
  • Busulfan
  • Cystitis (complications, virology)
  • Fatal Outcome
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents (adverse effects, therapeutic use)
  • Leukemia, Myeloid, Chronic-Phase (complications, therapy)
  • Lymphocyte Count
  • Lymphocyte Subsets
  • Male
  • Methylprednisolone (adverse effects, therapeutic use)
  • Middle Aged
  • Pneumonia, Viral (etiology, virology)
  • T-Lymphocytes
  • Tacrolimus (adverse effects, therapeutic use)
  • Transplantation Conditioning
  • Transplantation, Homologous
  • Vidarabine (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: